Oncology & Cancer

Adolescent glioma subtype responds to CDK4/6 inhibitor

CDK4/6 inhibitors, which are already FDA approved for the treatment of other forms of cancer, show early signs of promise in the treatment of a subtype of pediatric high-grade glioma, according to new research from Dana-Farber ...

Medical research

Key mechanisms identified for regeneration of neurons

Neurological disorders, such as trauma, stroke, epilepsy, and various neurodegenerative diseases, often lead to the permanent loss of neurons, causing significant impairments in brain function. Current treatment options are ...

page 1 from 33